Global Analgesics in Guatemala market Audience, Geographies and Key Players Forecast year
After seeing strong growth in 2019, analgesics is expected to see an even stronger performance in 2020 overall. The outbreak of COVID-19 has led to a surge in demand for analgesics in Guatemala that is set to continue throughout the rest of the year. Demand has been generated by both consumers infected with the virus and thus turning to OTC remedies to relieve symptoms, and consumers afraid of a future shortage and therefore stockpiling. India, which is the largest supplier of both ingredients a...
Euromonitor International's Analgesics in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table of Content
Analgesics in Guatemala
Euromonitor International
November 2020
List OF CONTENTS AND TABLES
KEY DATA FINDINGS
2020 IMPACT
Analgesics benefits from restricted exports that led to stockpiling
Small prices difference allows leading player Bayer to compete with generics
Acetaminophen the preferred OTC to relieve COVID-19 symptoms
RECOVERY AND OPPORTUNITIES
Slowed growth rates expected post lockdown as the pandemic eases
Consumers likely to favour effectiveness over cost
Self-medication will contribute to steady growth over the forecast period
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
CONTACT DETAILS :
sales@wiseguyreports.com
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment